Assessing the burden of HPV-related cancers in Appalachia

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 1, 2013, Pages 90-96

  Reiter, Paul L ^a,b,c   Fisher, James L ^b   Hudson, Alana G ^d   Tucker, Thomas C ^e   Plascak, Jesse J ^c   Paskett, Electra D ^a,b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d West Virginia Department of Health and Human Resources   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Appalachia; Cancer; Disparities; HPV; Human papillomavirus

Indexed keywords

ADOLESCENT; ADULT; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; GYNECOLOGICAL EXAMINATION; HEALTH DISPARITY; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PHARYNX CANCER; RACE DIFFERENCE; SCHOOL CHILD; SEASONAL VARIATION; SEX RATIO; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

APPALACHIA; CANCER; DISPARITIES; HPV; HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; APPALACHIAN REGION; CARCINOMA; CHILD; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; INCIDENCE; MALE; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; YOUNG ADULT;

EID: 84874736426     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22389     Document Type: Article

References (45)

1. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011; 204:566-73; PMID:21791659; http://dx.doi.org/10.1093/infdis/jir341.
2. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-57; PMID:16991079; http://dx.doi.org/10.1086/507432.
3. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693-703; PMID:22282321; http://dx.doi.org/10.1001/jama.2012.101.
4. Reiter PL, Pendergraft WF 3rd, Brewer NT. Metaanalysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev 2010; 19:2916-31; PMID:20833971; http://dx.doi.org/10.1158/1055-9965.EPI-10-0576.
5. Parkin DM, Bray F. Chapter 2: The burden of HPVrelated cancers. Vaccine 2006; 24 Suppl 3:S3/11-25.
6. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113(Suppl):3036-46; PMID:18980286; http://dx.doi.org/10.1002/cncr.23764.
7. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467-75; PMID:15734974; http://dx.doi.org/10.1158/1055-9965.EPI-04-0551.
8. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers -United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012; 61:258-61; PMID:22513527.
9. Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46(Suppl):S20-6; PMID:20307840; http://dx.doi.org/10.1016/j.jadohealth. 2010.01.016.
10. Pollard K, Jacobsen LA. The Appalachian region: A data overview from the 2006-2010 American Community Survey. 2012. Available at: http://www.arc.gov/ assets/research-reports/PRB-DataOverview-2012.pdf.
11. Halverson JA. An analysis of disparities in health status and access to health care in the Appalachian region. 2004. Available at: http://www.arc.gov/ research/researchreportdetails.asp?REPORT-ID=82.
12. Wewers ME, Katz M, Fickle D, Paskett ED. Risky behaviors among Ohio Appalachian adults. Prev Chronic Dis 2006; 3:A127; PMID:16978502.
13. Appalachia Community Cancer Network. The Cancer Burden in Appalachia, 2009.
14. Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377:932-40; PMID:21367446; http://dx.doi.org/10. 1016/S0140-6736(10)62342-2.
15. Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control 2002; 13:839-46; PMID:12462549; http://dx.doi.org/10.1023/A:1020668232219.
16. Wingo PA, Tucker TC, Jamison PM, Martin H, McLaughlin C, Bayakly R, et al. Cancer in Appalachia, 2001-2003. Cancer 2008; 112:181-92; PMID:18000806; http://dx.doi.org/10.1002/cncr.23132.
17. Lengerich EJ, Tucker TC, Powell RK, Colsher P, Lehman E, Ward AJ, et al. Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia. J Rural Health 2005; 21:39-47; PMID:15667008; http://dx.doi.org/10. 1111/j.1748-0361.2005.tb00060.x.
18. Horner MJ, Altekruse SF, Zou Z, Wideroff L, Katki HA, Stinchcomb DG. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev 2011; 20:591-9; PMID:21266522; http://dx.doi.org/10.1158/1055-9965.EPI-10-1183.
19. Appalachia Community Cancer Network. Addressing the Cancer Burden in Appalachian Communities, 2010.
20. Hopenhayn C, King JB, Christian A, Huang B, Christian WJ. Variability of cervical cancer rates across 5 Appalachian states, 1998-2003. Cancer 2008; 113(Suppl):2974-80; PMID:18980281; http://dx.doi.org/10.1002/cncr.23749.
21. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/caac.20138.
22. Grunbaum JA, Kann L, Kinchen S, Ross J, Hawkins J, Lowry R, et al. Youth risk behavior surveillance-United States, 2003. MMWR Surveill Summ 2004; 53:1-96; PMID:15152182.
23. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: USA Department of Health and Human Services, Centers for Disease Control and Prevention. 2010.
24. Ohio Behavioral Risk Factor Surveillance System. Columbus, OH: Ohio Department of Health. 2010.
25. Kentucky Behavioral Risk Factor Surveillance System. 2008 annual report. Available at: http://chfs.ky.gov/NR/rdonlyres/73E49DF2-81D3-4E05-BDC3- DA348F4E7F1E/0/Kentucky2008BRFSSAnnualReport.pdf.
26. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society, 2012.
27. Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women. Cancer Epidemiol Biomarkers Prev 2002; 11:137-42; PMID:11815412.
28. Paskett ED, McLaughlin JM, Reiter PL, Lehman AM, Rhoda DA, Katz ML, et al. Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project. Prev Med 2010; 50:74-80; PMID:19744509; http://dx.doi.org/10.1016/j.ypmed.2009. 09.001.
29. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626-9; PMID:20508593.
30. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1705-8; PMID:22189893.
31. USA Food and Drug Administration. Gardasil. 2011. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM094042.
32. USA Food and Drug Administration. Cervarix. 2011. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186957. htm.
33. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years -United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:671-7; PMID:22932301.
34. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine 2011; 29:5595-602; PMID:21704104; http://dx.doi.org/10.1016/j. vaccine.2011.06.020.
35. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 2009; 27:3945-52; PMID:19389447; http://dx.doi.org/10.1016/j.vaccine.2009.04.040.
36. Katz ML, Reiter PL, Kluhsman BC, Kennedy S, Dwyer S, Schoenberg N, et al. Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine 2009; 27:3195-200; PMID:19446191; http://dx.doi.org/10.1016/j.vaccine.2009.03.042.
37. Christian WJ, Christian A, Hopenhayn C. Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health 2009; 44:437-45; PMID:19380090; http://dx.doi.org/10.1016/j.jadohealth. 2008.09.001.
38. Hopenhayn C, Christian A, Christian WJ, Schoenberg NE. Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky counties. Cancer Causes Control 2007; 18:627-34; PMID:17497223; http://dx.doi.org/10.1007/s10552-007-9007-7.
39. Oldach BR, Katz ML. Ohio Appalachia public health department personnel: Human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents. J Community Health 2012; In press; PMID:22968822; http://dx.doi.org/10.1007/s10900-012-9613-5.
40. National Cancer Institute. Surveillance, Epidemiology and End Results. 2012. Available at: http://seer.cancer. gov/.
41. International Classification of Diseases for Oncology. Third edition. World Health Organization. 2000.
42. Appalachian Regional Commission. Counties in Appalachia. 2012. Available at: http://www.arc.gov/counties.
43. National Cancer Institute. SEER*Stat sofware version 7.0.4. 2011. Available at: http://seer.cancer.gov/seerstat/.
44. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006; 15:547-69; PMID:17260923; http://dx.doi.org/10.1177/0962280206070621.
45. Schenker N, Gentleman JF. On judging the significance of differences by examining the overlap between confidence intervals. Am Stat 2001; 55:182-6; http://dx.doi.org/10.1198/000313001317097960.